← All Envoy Medical, INC filings

Envoy Medical, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
COCH
Envoy Medical, INC
DEF: Envoy Medical 2026 Proxy Statement Overview
Envoy Medical's 2026 proxy statement outlines key proposals including director elections, auditor ratification, and significant equity plan amendments.
NASDAQ
COCH
Envoy Medical, INC
DEF: Envoy Medical Seeks Shareholder Approval for Warrant Issuance
Envoy Medical, Inc. calls a Special Meeting to approve the issuance of warrants and underlying Class A Common Stock to comply with Nasdaq listing rules following a recent securities offering.
NASDAQ
COCH
Envoy Medical, INC
DEFA14A: Envoy Medical Sets Date for Annual Stockholder Meeting, Seeks Approval on Key Proposals
Envoy Medical will hold its annual stockholder meeting on May 28, 2025, seeking votes on director elections, auditor ratification, executive compensation, and an equity incentive plan amendment.
NASDAQ
COCH
Envoy Medical, INC
DEF: Envoy Medical Seeks Stockholder Approval for Director Elections, Auditor Ratification, Executive Pay, and Equity Incentive Plan Amendment
Envoy Medical is holding its 2025 Annual Meeting of Stockholders to vote on key proposals including the election of directors, ratification of the auditor, executive compensation, and an amendment to the equity incentive plan.
NASDAQ
COCH
Envoy Medical, INC
DEFA14A: Envoy Medical, Inc. Files Definitive Additional Proxy Materials with SEC
Envoy Medical, Inc. has filed definitive additional materials related to its proxy statement with the Securities and Exchange Commission.
NASDAQ
COCH
Envoy Medical, INC
DEF 14A: Envoy Medical Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
Envoy Medical will hold its 2024 Annual Meeting of Stockholders on November 14, 2024, to vote on director elections, auditor ratification, executive compensation, and other matters.